| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostheses and Implants | 23 | 2021 | 132 | 5.870 |
Why?
|
| Metals | 23 | 2021 | 96 | 5.250 |
Why?
|
| Inflammation | 14 | 2021 | 231 | 3.320 |
Why?
|
| Prosthesis Failure | 25 | 2021 | 414 | 2.890 |
Why?
|
| Cobalt | 18 | 2016 | 71 | 2.570 |
Why?
|
| Hip Prosthesis | 20 | 2021 | 437 | 2.540 |
Why?
|
| Macrophages | 13 | 2021 | 89 | 2.390 |
Why?
|
| Osteolysis | 13 | 2021 | 113 | 2.240 |
Why?
|
| Lymphocyte Activation | 10 | 2020 | 76 | 2.130 |
Why?
|
| Materials Testing | 15 | 2021 | 102 | 2.030 |
Why?
|
| Alloys | 15 | 2017 | 77 | 2.030 |
Why?
|
| Hypersensitivity | 11 | 2021 | 38 | 2.020 |
Why?
|
| Cytokines | 18 | 2019 | 202 | 2.000 |
Why?
|
| Arthroplasty, Replacement | 10 | 2021 | 124 | 1.940 |
Why?
|
| Titanium | 23 | 2018 | 139 | 1.810 |
Why?
|
| Biocompatible Materials | 11 | 2011 | 69 | 1.700 |
Why?
|
| Prosthesis Design | 15 | 2021 | 384 | 1.670 |
Why?
|
| Arthroplasty, Replacement, Hip | 19 | 2021 | 686 | 1.670 |
Why?
|
| Lymphocytes | 7 | 2021 | 51 | 1.600 |
Why?
|
| Chromium | 14 | 2016 | 56 | 1.530 |
Why?
|
| Metal-on-Metal Joint Prostheses | 5 | 2017 | 33 | 1.510 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 4 | 2021 | 8 | 1.470 |
Why?
|
| Joint Prosthesis | 8 | 2019 | 70 | 1.390 |
Why?
|
| Hypersensitivity, Delayed | 5 | 2019 | 7 | 1.360 |
Why?
|
| Breast Implants | 2 | 2021 | 5 | 1.300 |
Why?
|
| Inflammasomes | 4 | 2021 | 9 | 1.280 |
Why?
|
| Nickel | 8 | 2019 | 20 | 1.240 |
Why?
|
| Humans | 75 | 2021 | 22947 | 1.160 |
Why?
|
| Intervertebral Disc | 7 | 2013 | 114 | 1.120 |
Why?
|
| Signal Transduction | 7 | 2019 | 398 | 1.080 |
Why?
|
| Foreign Bodies | 3 | 2020 | 20 | 1.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 14 | 2018 | 165 | 1.080 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2016 | 25 | 1.070 |
Why?
|
| Caspase 1 | 5 | 2021 | 7 | 1.060 |
Why?
|
| Vitallium | 5 | 2013 | 21 | 1.040 |
Why?
|
| Animals | 29 | 2021 | 3295 | 1.030 |
Why?
|
| Monocytes | 7 | 2016 | 43 | 1.010 |
Why?
|
| Particle Size | 12 | 2014 | 38 | 0.990 |
Why?
|
| Scoliosis | 2 | 2018 | 33 | 0.930 |
Why?
|
| Stainless Steel | 6 | 2018 | 13 | 0.910 |
Why?
|
| Immunity, Innate | 5 | 2021 | 55 | 0.880 |
Why?
|
| Arthralgia | 2 | 2017 | 100 | 0.870 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 2 | 2021 | 3 | 0.850 |
Why?
|
| Chromium Alloys | 5 | 2018 | 28 | 0.850 |
Why?
|
| Interleukin-1beta | 8 | 2016 | 37 | 0.790 |
Why?
|
| Male | 35 | 2021 | 12458 | 0.780 |
Why?
|
| Epidural Space | 4 | 2013 | 19 | 0.770 |
Why?
|
| Ions | 3 | 2012 | 45 | 0.770 |
Why?
|
| Osteoblasts | 5 | 2014 | 52 | 0.750 |
Why?
|
| Polyethylene | 4 | 2013 | 93 | 0.720 |
Why?
|
| Female | 34 | 2021 | 12954 | 0.710 |
Why?
|
| Breast Implantation | 1 | 2021 | 3 | 0.700 |
Why?
|
| Knee Prosthesis | 4 | 2017 | 200 | 0.690 |
Why?
|
| Urethane | 3 | 2010 | 3 | 0.670 |
Why?
|
| Polycarboxylate Cement | 3 | 2010 | 5 | 0.670 |
Why?
|
| Wounds, Penetrating | 1 | 2020 | 4 | 0.650 |
Why?
|
| Immunoglobulins | 1 | 2020 | 10 | 0.650 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2012 | 94 | 0.630 |
Why?
|
| Military Personnel | 1 | 2020 | 37 | 0.630 |
Why?
|
| Adult | 23 | 2021 | 6923 | 0.610 |
Why?
|
| Polyethylenes | 5 | 2015 | 30 | 0.600 |
Why?
|
| Orthopedic Procedures | 6 | 2019 | 225 | 0.600 |
Why?
|
| Corrosion | 13 | 2021 | 88 | 0.590 |
Why?
|
| Th17 Cells | 1 | 2019 | 23 | 0.590 |
Why?
|
| Lumbar Vertebrae | 7 | 2013 | 353 | 0.560 |
Why?
|
| Ketones | 3 | 2013 | 19 | 0.550 |
Why?
|
| Hip Joint | 3 | 2015 | 242 | 0.550 |
Why?
|
| Polyethylene Glycols | 3 | 2013 | 36 | 0.540 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 2 | 2009 | 26 | 0.540 |
Why?
|
| Polymers | 5 | 2013 | 36 | 0.520 |
Why?
|
| Middle Aged | 24 | 2021 | 7910 | 0.510 |
Why?
|
| Metals, Heavy | 1 | 2016 | 4 | 0.500 |
Why?
|
| Particulate Matter | 2 | 2013 | 16 | 0.500 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2016 | 32 | 0.490 |
Why?
|
| Coated Materials, Biocompatible | 4 | 2011 | 39 | 0.490 |
Why?
|
| Rabbits | 8 | 2018 | 165 | 0.480 |
Why?
|
| Aged | 22 | 2021 | 7447 | 0.480 |
Why?
|
| Lymphocyte Subsets | 1 | 2015 | 6 | 0.480 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2015 | 2 | 0.480 |
Why?
|
| Cells, Cultured | 7 | 2019 | 468 | 0.470 |
Why?
|
| Fibroblasts | 3 | 2012 | 50 | 0.470 |
Why?
|
| Osteoporosis | 1 | 2016 | 73 | 0.460 |
Why?
|
| Mice | 8 | 2021 | 1250 | 0.440 |
Why?
|
| Vanadium | 3 | 2014 | 3 | 0.430 |
Why?
|
| Foreign-Body Reaction | 4 | 2014 | 16 | 0.430 |
Why?
|
| Elasticity | 3 | 2009 | 25 | 0.420 |
Why?
|
| Adsorption | 1 | 2014 | 4 | 0.420 |
Why?
|
| Fibronectins | 1 | 2014 | 17 | 0.420 |
Why?
|
| Serum Albumin | 1 | 2014 | 21 | 0.420 |
Why?
|
| Cell Survival | 6 | 2014 | 99 | 0.420 |
Why?
|
| Cell Line | 7 | 2016 | 250 | 0.410 |
Why?
|
| Interleukin-6 | 7 | 2018 | 70 | 0.410 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 67 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 370 | 0.410 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 8 | 0.400 |
Why?
|
| Equipment Failure Analysis | 4 | 2011 | 79 | 0.400 |
Why?
|
| Surface Properties | 10 | 2021 | 105 | 0.400 |
Why?
|
| Lysosomes | 1 | 2013 | 20 | 0.400 |
Why?
|
| Bone Development | 1 | 2013 | 29 | 0.400 |
Why?
|
| Models, Animal | 8 | 2013 | 103 | 0.390 |
Why?
|
| Adaptive Immunity | 3 | 2020 | 12 | 0.390 |
Why?
|
| Spinal Diseases | 2 | 2012 | 106 | 0.380 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 232 | 0.380 |
Why?
|
| In Vitro Techniques | 5 | 2019 | 153 | 0.380 |
Why?
|
| Tensile Strength | 3 | 2009 | 20 | 0.380 |
Why?
|
| Intervertebral Disc Displacement | 3 | 2011 | 74 | 0.370 |
Why?
|
| Freezing | 2 | 2009 | 11 | 0.370 |
Why?
|
| Nanoparticles | 1 | 2011 | 10 | 0.360 |
Why?
|
| Apoptosis | 5 | 2009 | 196 | 0.360 |
Why?
|
| Time Factors | 6 | 2020 | 1262 | 0.350 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 3728 | 0.350 |
Why?
|
| Anterior Cruciate Ligament | 3 | 2009 | 137 | 0.350 |
Why?
|
| Molybdenum | 5 | 2016 | 15 | 0.340 |
Why?
|
| Weight-Bearing | 5 | 2008 | 134 | 0.330 |
Why?
|
| Cross-Linking Reagents | 1 | 2010 | 10 | 0.320 |
Why?
|
| Interleukin-17 | 2 | 2021 | 12 | 0.320 |
Why?
|
| Blood Proteins | 5 | 2007 | 17 | 0.310 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 50 | 0.310 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 94 | 0.310 |
Why?
|
| Suture Techniques | 2 | 2007 | 112 | 0.310 |
Why?
|
| X-Ray Microtomography | 4 | 2021 | 73 | 0.300 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2994 | 0.290 |
Why?
|
| Toxicity Tests | 1 | 2008 | 8 | 0.290 |
Why?
|
| DNA Damage | 1 | 2008 | 25 | 0.290 |
Why?
|
| Cell Proliferation | 4 | 2012 | 163 | 0.290 |
Why?
|
| Spine | 2 | 2013 | 98 | 0.290 |
Why?
|
| Cell Adhesion | 2 | 2001 | 30 | 0.280 |
Why?
|
| Benzophenones | 3 | 2013 | 21 | 0.280 |
Why?
|
| Rotator Cuff | 2 | 2007 | 213 | 0.270 |
Why?
|
| Osteocytes | 3 | 2014 | 18 | 0.270 |
Why?
|
| Risk Assessment | 2 | 2009 | 548 | 0.270 |
Why?
|
| Postoperative Complications | 4 | 2019 | 811 | 0.260 |
Why?
|
| Extracellular Matrix | 2 | 2008 | 49 | 0.250 |
Why?
|
| Biomarkers | 5 | 2021 | 476 | 0.250 |
Why?
|
| Ultrasonic Therapy | 1 | 2006 | 21 | 0.250 |
Why?
|
| Hindlimb | 1 | 2006 | 15 | 0.250 |
Why?
|
| Bone and Bones | 4 | 2014 | 107 | 0.240 |
Why?
|
| Rotation | 1 | 2006 | 109 | 0.240 |
Why?
|
| Radiculopathy | 1 | 2006 | 41 | 0.240 |
Why?
|
| Young Adult | 3 | 2017 | 1651 | 0.240 |
Why?
|
| Microbial Collagenase | 1 | 2005 | 12 | 0.230 |
Why?
|
| Collagen | 1 | 2005 | 81 | 0.230 |
Why?
|
| Cell Transplantation | 1 | 2005 | 15 | 0.230 |
Why?
|
| Skull | 3 | 2021 | 16 | 0.230 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 336 | 0.230 |
Why?
|
| Tendon Injuries | 1 | 2006 | 154 | 0.220 |
Why?
|
| Rotator Cuff Injuries | 2 | 2007 | 226 | 0.220 |
Why?
|
| Skin Tests | 1 | 2004 | 6 | 0.220 |
Why?
|
| Pain Measurement | 3 | 2017 | 412 | 0.220 |
Why?
|
| Random Allocation | 4 | 2013 | 103 | 0.220 |
Why?
|
| Metal Ceramic Alloys | 1 | 2004 | 2 | 0.210 |
Why?
|
| Cell Migration Inhibition | 2 | 2001 | 2 | 0.210 |
Why?
|
| Bone Resorption | 3 | 2021 | 75 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 75 | 0.210 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2000 | 11 | 0.210 |
Why?
|
| Biofilms | 1 | 2003 | 13 | 0.200 |
Why?
|
| Phagocytosis | 4 | 2013 | 25 | 0.200 |
Why?
|
| Synovial Fluid | 3 | 2013 | 82 | 0.190 |
Why?
|
| Arthroplasty, Replacement, Knee | 3 | 2017 | 560 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 523 | 0.190 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2021 | 125 | 0.190 |
Why?
|
| Implants, Experimental | 3 | 2010 | 32 | 0.180 |
Why?
|
| Biomechanical Phenomena | 5 | 2011 | 536 | 0.180 |
Why?
|
| Orthopedics | 3 | 2014 | 77 | 0.180 |
Why?
|
| Absorbable Implants | 1 | 2001 | 17 | 0.180 |
Why?
|
| Silicones | 1 | 2021 | 10 | 0.180 |
Why?
|
| Scattering, Radiation | 2 | 2012 | 32 | 0.170 |
Why?
|
| Preoperative Period | 1 | 2021 | 65 | 0.170 |
Why?
|
| Biomedical Engineering | 1 | 2001 | 5 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2013 | 88 | 0.170 |
Why?
|
| Reactive Oxygen Species | 2 | 2013 | 104 | 0.170 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2011 | 64 | 0.170 |
Why?
|
| Interferon-gamma | 1 | 2021 | 72 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2020 | 370 | 0.170 |
Why?
|
| Body Fluids | 3 | 2010 | 11 | 0.170 |
Why?
|
| Light | 2 | 2012 | 55 | 0.170 |
Why?
|
| Drug Hypersensitivity | 1 | 2000 | 6 | 0.170 |
Why?
|
| Sex Characteristics | 1 | 2021 | 85 | 0.160 |
Why?
|
| Mice, Knockout | 2 | 2019 | 282 | 0.160 |
Why?
|
| Interleukins | 2 | 2012 | 21 | 0.160 |
Why?
|
| Pandemics | 1 | 2021 | 206 | 0.160 |
Why?
|
| Aluminum | 3 | 2014 | 6 | 0.150 |
Why?
|
| Oxides | 1 | 2019 | 13 | 0.150 |
Why?
|
| Thermodynamics | 1 | 2019 | 42 | 0.150 |
Why?
|
| Age Factors | 1 | 2021 | 635 | 0.150 |
Why?
|
| Interleukin-33 | 1 | 2019 | 2 | 0.150 |
Why?
|
| Prospective Studies | 7 | 2013 | 1493 | 0.150 |
Why?
|
| Models, Immunological | 1 | 2019 | 4 | 0.150 |
Why?
|
| Stress, Mechanical | 4 | 2007 | 129 | 0.150 |
Why?
|
| Swine | 3 | 2009 | 68 | 0.150 |
Why?
|
| Molecular Weight | 2 | 2014 | 22 | 0.150 |
Why?
|
| Solubility | 3 | 2009 | 22 | 0.140 |
Why?
|
| Spinal Cord | 2 | 2013 | 74 | 0.140 |
Why?
|
| Dinoprostone | 2 | 2010 | 16 | 0.140 |
Why?
|
| Electrochemistry | 4 | 2017 | 39 | 0.140 |
Why?
|
| Models, Theoretical | 1 | 2017 | 76 | 0.130 |
Why?
|
| Spinal Fusion | 4 | 2018 | 429 | 0.130 |
Why?
|
| Cattle | 2 | 2016 | 111 | 0.130 |
Why?
|
| Necrosis | 2 | 2008 | 24 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2018 | 173 | 0.130 |
Why?
|
| Fibrosis | 2 | 2013 | 30 | 0.130 |
Why?
|
| Macrophage Activation | 2 | 2013 | 7 | 0.130 |
Why?
|
| Lipopeptides | 1 | 2016 | 8 | 0.130 |
Why?
|
| Patellar Ligament | 2 | 2009 | 35 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 85 | 0.120 |
Why?
|
| Cell Death | 2 | 2014 | 34 | 0.120 |
Why?
|
| Phenylpropionates | 1 | 2015 | 1 | 0.120 |
Why?
|
| Propylene Glycols | 1 | 2015 | 1 | 0.120 |
Why?
|
| Prosthesis-Related Infections | 2 | 2010 | 177 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 384 | 0.120 |
Why?
|
| Inflammation Mediators | 4 | 2011 | 58 | 0.120 |
Why?
|
| Neoplasms | 3 | 2009 | 216 | 0.110 |
Why?
|
| Osteogenesis | 1 | 2015 | 99 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2013 | 144 | 0.110 |
Why?
|
| Chemokines | 1 | 2014 | 15 | 0.110 |
Why?
|
| Bioreactors | 1 | 2014 | 6 | 0.100 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 29 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 31 | 0.100 |
Why?
|
| Cathepsin B | 1 | 2013 | 3 | 0.100 |
Why?
|
| Neurotoxins | 1 | 2013 | 13 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 8 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 27 | 0.100 |
Why?
|
| Age of Onset | 1 | 2013 | 71 | 0.100 |
Why?
|
| Osteoclasts | 4 | 2013 | 20 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 76 | 0.100 |
Why?
|
| Compressive Strength | 2 | 2010 | 13 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 67 | 0.100 |
Why?
|
| Rats | 3 | 2010 | 626 | 0.100 |
Why?
|
| Antioxidants | 1 | 2013 | 56 | 0.100 |
Why?
|
| Zirconium | 1 | 2012 | 4 | 0.090 |
Why?
|
| Mouth | 1 | 2012 | 12 | 0.090 |
Why?
|
| Dental Implants | 1 | 2012 | 9 | 0.090 |
Why?
|
| Lasers | 1 | 2011 | 14 | 0.090 |
Why?
|
| Th2 Cells | 1 | 2011 | 15 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 315 | 0.090 |
Why?
|
| Child, Preschool | 1 | 2013 | 567 | 0.090 |
Why?
|
| Lumbosacral Region | 1 | 2012 | 51 | 0.090 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 9 | 0.090 |
Why?
|
| Calcineurin | 1 | 2011 | 8 | 0.090 |
Why?
|
| Joint Diseases | 1 | 2012 | 87 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 244 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2004 | 481 | 0.090 |
Why?
|
| Osteoarthritis | 2 | 2005 | 283 | 0.080 |
Why?
|
| Immunity, Cellular | 2 | 2001 | 33 | 0.080 |
Why?
|
| Protein Binding | 2 | 2001 | 114 | 0.080 |
Why?
|
| Adolescent | 2 | 2013 | 1881 | 0.080 |
Why?
|
| Arthroplasty | 2 | 2019 | 107 | 0.080 |
Why?
|
| B7-2 Antigen | 1 | 2010 | 1 | 0.080 |
Why?
|
| B7-1 Antigen | 1 | 2010 | 4 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 12 | 0.080 |
Why?
|
| Chronic Pain | 1 | 2012 | 127 | 0.080 |
Why?
|
| United States | 2 | 2014 | 1765 | 0.080 |
Why?
|
| Proteins | 1 | 2010 | 52 | 0.080 |
Why?
|
| Patient Selection | 2 | 2009 | 167 | 0.080 |
Why?
|
| Software | 1 | 2010 | 50 | 0.080 |
Why?
|
| Neutrophils | 1 | 2010 | 91 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 80 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2010 | 102 | 0.080 |
Why?
|
| Child | 1 | 2013 | 1157 | 0.080 |
Why?
|
| Therapeutic Irrigation | 2 | 2007 | 44 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2010 | 77 | 0.080 |
Why?
|
| NADP | 1 | 2009 | 8 | 0.080 |
Why?
|
| Sus scrofa | 1 | 2009 | 5 | 0.080 |
Why?
|
| Range of Motion, Articular | 1 | 2011 | 564 | 0.080 |
Why?
|
| Phagocytes | 1 | 2009 | 20 | 0.070 |
Why?
|
| Jurkat Cells | 1 | 2008 | 8 | 0.070 |
Why?
|
| Calcium Phosphates | 2 | 2005 | 16 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 315 | 0.070 |
Why?
|
| Cryopreservation | 1 | 2008 | 12 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 439 | 0.070 |
Why?
|
| Interleukin-1 | 2 | 2006 | 46 | 0.070 |
Why?
|
| Friction | 2 | 2017 | 16 | 0.070 |
Why?
|
| Menisci, Tibial | 1 | 2008 | 94 | 0.070 |
Why?
|
| Algorithms | 1 | 2009 | 304 | 0.070 |
Why?
|
| Knee Joint | 2 | 2009 | 572 | 0.060 |
Why?
|
| Back Pain | 1 | 2007 | 52 | 0.060 |
Why?
|
| Acetabulum | 1 | 2008 | 161 | 0.060 |
Why?
|
| Procollagen | 2 | 2004 | 4 | 0.060 |
Why?
|
| Cell Division | 2 | 2004 | 80 | 0.060 |
Why?
|
| Wound Healing | 1 | 2006 | 108 | 0.060 |
Why?
|
| Growth Substances | 2 | 2005 | 27 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2006 | 47 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 16 | 0.060 |
Why?
|
| Acute Disease | 1 | 2006 | 163 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2006 | 210 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2005 | 65 | 0.060 |
Why?
|
| Durapatite | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cell Shape | 1 | 2005 | 6 | 0.060 |
Why?
|
| Fracture Healing | 1 | 2005 | 31 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2005 | 31 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2004 | 284 | 0.060 |
Why?
|
| Environmental Monitoring | 1 | 2004 | 9 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 82 | 0.060 |
Why?
|
| Bone Regeneration | 1 | 2005 | 67 | 0.060 |
Why?
|
| Calcitriol | 1 | 2004 | 2 | 0.050 |
Why?
|
| Reoperation | 4 | 2010 | 743 | 0.050 |
Why?
|
| Diphosphonates | 1 | 2004 | 16 | 0.050 |
Why?
|
| Risk Factors | 2 | 2006 | 1970 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2003 | 22 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 176 | 0.050 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2003 | 19 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 173 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 20 | 0.050 |
Why?
|
| Culture Media | 1 | 2002 | 30 | 0.050 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2003 | 143 | 0.050 |
Why?
|
| Models, Biological | 1 | 2003 | 303 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 32 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2001 | 9 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 24 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2001 | 13 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2001 | 40 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2001 | 84 | 0.040 |
Why?
|
| Methods | 1 | 2000 | 12 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 2000 | 28 | 0.040 |
Why?
|
| Gene Expression | 2 | 2011 | 178 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 537 | 0.040 |
Why?
|
| Mechanical Phenomena | 1 | 2017 | 20 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2013 | 2941 | 0.030 |
Why?
|
| Pain, Postoperative | 2 | 2010 | 272 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 592 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2014 | 5 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 69 | 0.030 |
Why?
|
| Endotoxins | 1 | 2013 | 9 | 0.030 |
Why?
|
| Radiography | 2 | 2007 | 521 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 24 | 0.020 |
Why?
|
| Femur | 2 | 2005 | 298 | 0.020 |
Why?
|
| Acid Phosphatase | 2 | 2003 | 3 | 0.020 |
Why?
|
| Cell Count | 2 | 2003 | 72 | 0.020 |
Why?
|
| Ilium | 2 | 2003 | 28 | 0.020 |
Why?
|
| Osteoarthritis, Hip | 1 | 2013 | 81 | 0.020 |
Why?
|
| Device Removal | 1 | 2012 | 68 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2011 | 6 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 18 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 14 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 95 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2011 | 30 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 126 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 311 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2011 | 70 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 109 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 112 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 26 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2010 | 47 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 110 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 168 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 1412 | 0.020 |
Why?
|
| Chromium Compounds | 1 | 2009 | 3 | 0.020 |
Why?
|
| Phosphates | 1 | 2009 | 16 | 0.020 |
Why?
|
| Interferometry | 1 | 2008 | 6 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 12 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 17 | 0.020 |
Why?
|
| Femoral Neck Fractures | 1 | 2008 | 9 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2008 | 120 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 198 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cadaver | 1 | 2007 | 283 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2006 | 22 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Debridement | 1 | 2006 | 66 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2006 | 126 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 2005 | 5 | 0.010 |
Why?
|
| Shear Strength | 1 | 2005 | 7 | 0.010 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2005 | 13 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 28 | 0.010 |
Why?
|
| Femoral Fractures | 1 | 2005 | 30 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 164 | 0.010 |
Why?
|
| Ceramics | 1 | 2005 | 13 | 0.010 |
Why?
|
| Osteonectin | 1 | 2004 | 5 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2004 | 17 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 31 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2004 | 33 | 0.010 |
Why?
|
| Glycocalyx | 1 | 2003 | 1 | 0.010 |
Why?
|
| Myelography | 1 | 2003 | 4 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 59 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 860 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2003 | 98 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2003 | 48 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 243 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 577 | 0.010 |
Why?
|
| Knee Injuries | 1 | 2003 | 127 | 0.010 |
Why?
|
| Bone Transplantation | 1 | 2002 | 155 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2003 | 271 | 0.010 |
Why?
|
| Porosity | 1 | 1998 | 54 | 0.010 |
Why?
|
| Bone Cements | 1 | 1998 | 78 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 1046 | 0.010 |
Why?
|